Month: July 2020

LONDON, July 22, 2020 (GLOBE NEWSWIRE) — Rackspace Technology™ today announced that Aramex, a leading global provider of comprehensive logistics and transportation solutions, is in the process of migrating from on-premise data centres to Amazon Web Services (AWS) following a comprehensive Professional Services consultation.Aramex, which moved more than 103 million shipments globally last year, started its cloud journey with the creation of one of the largest data lakes in the Middle East and the deployment of machine learning models in areas of customer experience and last mile innovation.Through the managed public cloud environment, the Dubai-based organization has already achieved cost savings when scaling, which was crucial during the early months of the Covid-19 pandemic where it saw around 30-40% growth in e-commerce volumes....

Grant of European patent entitled ‘Osteoinductive composites’Notice of allowance of Japanese patent from the same patent familyFurther strengthens Kuros’s position as a leader in the field of orthobiologicsSCHLIEREN (ZURICH), Switzerland, July 22, 2020 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX: KURN) today announced that its Dutch subsidiary, Kuros Biosciences BV, has been granted the European patent, EP 3268058, entitled ‘Osteoinductive composites’. This patent covers certain combinations of polymers and granular materials and further expands Kuros’s patent portfolio relating to its MagnetOs product line. Kuros has also received notice of allowance of a patent application from the same patent family in Japan.Kuros has over 20 granted patents and more than 10 patents pending, specifically in the field of bone graft technologies,...

Rotterdam, the Netherlands, 22 July 2020AttachmentDownload full press release

                 An open-air cinema from your car in complete physical and digital security.The OISTE Foundation (www.oiste.org) is pleased to support the young and dynamic team of Ciné Park Bernex, which has launched a series of 16 movie projection in the form of “drive-in”, every weekend during the months of July and August.In these difficult times of Covid-19, the OISTE Foundation supports projects active in the protection of people, not only digitally but also physically. Ciné Park Bernex Drive-In offers screenings for cinema enthusiasts based on a concept from the 60s, allowing them to watch current and classic movies from their car, outdoors and in complete safety. The entire program is available on the website https://www.cinepark-drive.ch/.OISTE is a foundation under Swiss law created in 1998 with the aim of promoting...

                 Un cinéma en plein air depuis sa voiture en toute sécurité physique et digitaleLa Fondation OISTE (www.oiste.org) a le plaisir de soutenir la jeune et dynamique équipe de Ciné Park Bernex qui s’est lancée pour une programmation de 16 films sous forme de projections « car drive » tous les week-ends durant les mois de juillet et août.Dans ces temps difficiles du Covid-19, la Fondation OISTE souhaite ainsi soutenir des projets actifs dans la protection des personnes, non seulement digitalement mais également physiquement. Ciné Park Bernex Drive-In propose des séances pour les cinéphiles basées sur un concept des années 60 permettant d’assister à une projection de films actuels et rétros, depuis sa voiture, en plein air et en toute sécurité. L’entier de la programmation est disponible sur le site  https://www.cinepark-drive.ch/.OISTE...

CD38KO NK cell therapy has the potential to maximize the efficacy of anti-CD38 against multiple myelomaAmsterdam, The Netherlands, July 22, 2020 – Kiadis Pharma N.V. (“Kiadis” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative cell therapeutics for life-threatening diseases, today announces publication of an article in Blood, Journal of the American Society of Hematology. The article describes the synergy of mbIL21 expanded NK cells (FC21-NK) modified with a CD38 gene knockout together with an anti-CD38 monoclonal antibody (mAb) for enhanced killing of multiple myeloma cells.The publication describes the use of the CRISPR/Cas9 system to delete CD38 (CD38KO) in ex vivo expanded peripheral blood K-NK cells, with 82% knock out efficiency. These CD38KO K-NK cells were...

22 July 2020: The shares in Scatec Solar ASA will be traded ex. dividend NOK 0.95 as from today, 22 July 2020.This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

July 22, 2020AkzoNobel’s Q2 results show strong focus on margin and cost savings in response to COVID-19 headwindsAkzo Nobel N.V. (AKZA; AKZOY) publishes results for second quarter 2020Highlights Q2 2020ROS, excluding unallocated costs1, increased to 14.0% (2019: 13.7%) due to strong margin management and cost savingsHeadwinds related to COVID-19 eased during the quarter, with revenue almost 30% lower in April and nearly 5% lower in JuneTotal cost savings delivered €116 million, of which €38 million structural savings related to transformation initiativesNet cash from operating activities improved to €308 million (2019: €152 million); maintained a strong balance sheetQ2 2020 (compared to Q2 2019)Revenue 19% lower and 17% lower in constant currencies, with positive price/mix of 2% and 18% lower volumes, mainly due to the impact of COVID-19Adjusted...

22 juli 2020Tweede kwartaal resultaten van AkzoNobel laten sterke focus op marge en kostenbesparingen zien als reactie op tegenwind van COVID-19Akzo Nobel N.V. (AKZA; AKZOY) publiceert resultaten voor tweede kwartaal 2020Hoogtepunten Q2 2020Rendement op verkopen1 (ROS), exclusief niet-toegewezen kosten, steeg naar 14,0% (2019: 13,7%) dankzij sterk margebeheer en kostenbesparingenDe tegenwind als gevolg van COVID-19 nam gedurende het kwartaal af, met een bijna 30% lagere omzet in april tegen een bijna 5% lagere omzet in juniHet bedrag aan totale kostenbesparingen was €116 miljoen, waarvan €38 miljoen aan structurele besparingen gerelateerd aan transformatie-initiatievenNetto kasstroom uit operationele activiteiten verbeterde tot €308 miljoen (2019: €152 miljoen); behoud van sterke balanspositieQ2 2020 (vergeleken met Q2 2019)Omzet 19%...

Polarcus Limited (“Polarcus” or the “Company”) (OSE: PLCS) releases its second quarter and preliminary half year results 2020.Polarcus CEO, Duncan Eley, commented:“As guided, the Company’s Q2 2020 results were negatively impacted by low utilization as E&P companies re-assessed their near-term exploration plans following the global economic slow-down which has also delayed tender processes.The outlook for the second half of 2020 remains challenging. However, the recent marine seismic industry restructuring alongside current oil price developments provide favourable foundations for activity levels to build during 2021.The substantial cost reduction initiatives and organizational reshape implemented by Polarcus during H1 2020, have enabled the Company to partly offset the adverse effects of the industry slow-down and preserve liquidity.“Q2...